Search
Search Results
-
Diagnostic value of serum CA125 combined with PET/CT in ovarian cancer and tuberculous peritonitis in female patients
PurposeTo evaluate the diagnostic value of serum CA125 combined with 18 F-FDG PET/CT in ovarian cancer (OC) and tuberculous peritonitis (TBP) in...
-
Role of Serum CA125 and HE4 in Predicting Optimal Cytoreduction in Advanced Epithelial Ovarian Cancer After Neoadjuvant Chemotherapy
AimTo evaluate the role of serum HE4 in predicting surgical outcome and platinum response in advanced stage EOC patients and to compare the results...
-
Prognostic significance of serum CA125 in the overall management for patients with gastrointestinal stromal tumors
BackgroundCarbohydrate antigen 125 (CA125) is elevated as a tumor marker in many carcinomas, but its association with gastrointestinal stromal tumor...
-
Clinical value of combined serum CA125, NSE and 24-hour urine VMA for the prediction of recurrence in children with neuroblastoma
BackgroundIn this study, we intend to retrospectively analyze the clinical data of postoperative neuroblastoma children, including the results of...
-
Evaluation of serum CA125-Tn glycoform in peritoneal dissemination and surgical completeness of high-grade serous ovarian cancer
BackgroundPeritoneal dissemination is the predominant feature of malignant progression in ovarian cancer and is a major cause of poor surgical...
-
Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of CA125, HE4, and C5a
ObjectiveInvestigating the utility of serum exosomal markers CA125, HE4, and C5a, both individually and in combination, for distinguishing between...
-
The value of CA125 in predicting acute complicated colonic diverticulitis
BackgroundCA125 is a widely used serum marker for epithelial ovarian cancer which levels may also rise in benign conditions involving peritoneal...
-
Metastasis of cervical cancer indicated by elevation of serum CA125 produced by mediastinal lymph nodes: a case report
BackgroundIn patient assessment for recurrence of neoplasia, a biomarker that shows an elevated serum value before the first treatment is a candidate...
-
Diagnostic value of an enhanced MRI combined with serum CEA, CA19-9, CA125 and CA72-4 in the liver metastasis of colorectal cancer
ObjectiveThis paper aims to explore the diagnostic value of enhanced magnetic resonance imaging (MRI) combined with a carcinoembryonic antigen (CEA)...
-
Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer
BackgroundCervical cancer shows great differences in depth of invasion, metastasis, and other biological behaviors. The location of the lesion is...
-
CA125: a novel cardiac biomarker for infants with congenital diaphragmatic hernia
BackgroundThe carbohydrate antigen 125 (CA125) was proven as a robust biomarker for risk stratification in adults with heart failure. This is the...
-
Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancer
BackgroundTo determine the potential of the combination of DCE-MRI imaging method with DWI and serum CA125 and CA199 levels in the evaluation of the...
-
Evaluation of Serum s EGFR in Ovarian Tumors, its Comparison with Serum CA125, HE4 and Correlation with Histopathological Types
Background and ObjectiveEGFR is deregulated, in several types of cancer, by three mechanisms: (1) activating gene mutations; (2) overexpression of...
-
Serum CA724 has no diagnostic value for gastrointestinal tumors
ObjectiveThis study aimed to explore the predictive values of serum carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 199, CA125 and CA724 in...
-
The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients
BackgroundThe fibrinogen to albumin ratio (FAR) is increasingly regarded as a potential biomarker for predicting prognosis in variety of malignant...
-
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
BackgroundThe mortality rate of ovarian cancer ranks first among three common gynecological malignant tumors due to insidious onset and lack of...
-
Preoperative serum level of CA153 and a new model to predict the sub-optimal primary debulking surgery in patients with advanced epithelial ovarian cancer
ObjectiveThe aim of this study was to establish a preoperative model to predict the outcome of primary debulking surgery (PDS) for advanced ovarian...
-
Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer
BackgroundMeasurement of serum CA125, an antigenic fragment of human mucin 16 (MUC16), is used to monitor the clinical progression of epithelial...
-
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
ObjectiveOvarian cancer is the most deadly deadliest gynecological tumor in the female reproductive system. Therefore, the present study sought to...
-
A Prospective Observational Case-Control Study of Serum HE4 as a Diagnostic Marker of Female Breast Malignancy in a Tertiary Care Center in North India
Human epididymis protein 4 (HE4) is a secretory protein encoded by the WFDC2 gene. The potential use of HE4 as a tumor marker has been supported by...
